References
Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, DiLenarda A, Komajda M, Remme WJ, Lutiger B, Schgerhag A, Lukas MA, Charlesworth A, Poole-Wilson PA (2005) Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 26:2259–2268
Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103:1428–1433
Peterson JW, Felker M (2008) Inotropes in the management of acute heart failure. Crit Care Med 36:S106–S111
Eklayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV (2007) Use and impact of inotropes and vasodilatatory therapy in hospitalized patients with severe heart failure. Am Heart J 153:98–104
Simon L, Ghalch B, Puybasset L, Giudicelli JF, Berdeaux A (1995) Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 275:659–666
Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group (2003) Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107:817–823
Fox K, Ferrari R, Tendera M, Steg PG, Ford I, BEAUTIFUL Steering Committee (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary heart disease and left ventricular systolic dysfunction: the morbidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction (BEAUTIFUL) Study. Am Heart J 152:860–866
De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L (2008) Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail 10:550–555
Hoppe UC, La Rosée K, Larbig R, Erdmann E (2007) Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy. Clin Res Cardiol 96:243–246
Reil JC, Böhm M (2007) The role of heart rate in the development of cardiovascular disease. Clin Res Cardiol 96:585–592
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Link, A., Reil, J.C., Selejan, S. et al. Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure. Clin Res Cardiol 98, 513–515 (2009). https://doi.org/10.1007/s00392-009-0038-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-009-0038-9